Carl Zeiss Meditech to Acquire Laser Company

In a move to strengthen its position in the glaucoma diagnosis market, Carl Zeiss Meditec, Inc. (Jena, Germany) has agreed to acquire Laser Diagnostic Technologies, Inc. (LDT, San Diego, CA, USA). Financial terms were not disclosed.

Carl Zeiss Meditec is a leading global provider of eye care solutions. The company's product line includes systems for the diagnosis and treatment of the four main diseases of the eye: refraction, cataract, glaucoma, and retinal disorders. The company has incorporated its technologically superior optics into a stream of product innovations, from slit lamps and fundus cameras to the Humphrey Field Analyzer, which is recognized as the global standard for glaucoma detection and management.

LDT's GDx VCC is a dedicated glaucoma diagnosis and management tool, while its Stratus OCT is a multipurpose retinal imaging system used not only for the diagnosis of glaucoma but also for a wide array of conditions, including age-related macular degeneration (AMD), diabetic retinopathy, and cataract assessment.

"This acquisition is another important milestone in our growth strategy,” remarked Jim Taylor, president and CEO of Carl Zeiss Meditec. "It will further strengthen our technology portfolio and undisputed leadership in the growing market of glaucoma diagnosis and management.”






Related Links:
Laser Diagnostic Tech
Carl Zeiss Meditec